Minimally invasive treatment of intertrochanteric hip fractures with the Gotfried percutaneous compression plate.

The treatment goal of intertrochanteric fractures is to maintain the patient’s quality of life. Recent studies have shown that intertrochanteric fractures can result in significant morbidity and mortality. Deficits in activities of daily living due to hip fractures resulted in considerable morbidity, mortality, and costs. The United States Center for Disease Control: National Center for Injury Prevention and Control reports “Of all fall-related fracture, hip fractures cause the greatest number of deaths and lead to the most severe health problems and reduced quality of life.” Approximately 300,000 hospital admissions for hip fractures occur annually, with the projected number to exceed 500,000 by the year 2040.